Topic
Amyloid-beta plaques
Lecanemab for Alzheimer's shows cognitive benefit despite serious risks
Lecanemab has demonstrated a statistically significant ability to reduce cognitive decline in early Alzheimer's patients, despite serious safety risks and high costs.